Recent hantavirus and Ebola outbreaks underscore that pandemic preparedness depends on rapid detection and response systems, not pathogen severity alone.
Richard Russell
Richard Russell is vice president of biometric research within RGA’s global research & development team.
He is a frequent speaker at conferences, seminars, and industry events, presenting on topics such as COVID-19 and emerging biometric trend drivers, including GLP-1 therapies and multi-cancer early detection technologies.
Russell holds a bachelor of science in biotechnology, a master of science in bioinformatics (with distinction), and a PhD in statistics, all from Imperial College London. He has written more than 30 peer-reviewed publications in leading journals, including the Lancet, BMJ Open, PLOS One, and Annals of Actuarial Science.
